Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Stefan James, Ole Fröbert et al.|American Heart Journal|2024Cited by 5